Literature DB >> 11898126

X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28.

Kimberly A Hahn1, Gajja S Salomons, Darci Tackels-Horne, Tim C Wood, Harold A Taylor, Richard J Schroer, Herbert A Lubs, Cornelis Jakobs, Rick L Olson, Kenton R Holden, Roger E Stevenson, Charles E Schwartz.   

Abstract

A family with X-linked mental retardation characterized by severe mental retardation, speech and behavioral abnormalities, and seizures in affected male patients has been found to have a G1141C transversion in the creatine-transporter gene SLC6A8. This mutation results in a glycine being replaced by an arginine (G381R) and alternative splicing, since the G-->C transversion occurs at the -1 position of the 5' splice junction of intron 7. Two female relatives who are heterozygous for the SLC6A8 mutation also exhibit mild mental retardation with behavior and learning problems. Male patients with the mutation have highly elevated creatine in their urine and have decreased creatine uptake in fibroblasts, which reflects the deficiency in creatine transport. The ability to measure elevated creatine in urine makes it possible to diagnose SLC6A8 deficiency in male patients with mental retardation of unknown etiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11898126      PMCID: PMC447610          DOI: 10.1086/340092

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  XLMR genes: update 1990.

Authors:  G Neri; F Gurrieri; A Gal; H A Lubs
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

2.  Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X-linked hydrocephalus.

Authors:  A Rosenthal; M Jouet; S Kenwrick
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

3.  Arginine kinase expression and localization in growth cone migration.

Authors:  Y E Wang; P Esbensen; D Bentley
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

4.  Renpenning syndrome maps to Xp11.

Authors:  R E Stevenson; J F Arena; E Ouzts; A Gibson; M H Shokeir; C Vnencak-Jones; H A Lubs; M May; C E Schwartz
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

5.  Cloning, pharmacological characterization, and genomic localization of the human creatine transporter.

Authors:  S R Nash; B Giros; S F Kingsmore; J M Rochelle; S T Suter; P Gregor; M F Seldin; M G Caron
Journal:  Recept Channels       Date:  1994

Review 6.  Creatine kinase in non-muscle tissues and cells.

Authors:  T Wallimann; W Hemmer
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

7.  Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism.

Authors:  S Stöckler; F Hanefeld; J Frahm
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

8.  X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene.

Authors:  M Jouet; A Rosenthal; G Armstrong; J MacFarlane; R Stevenson; J Paterson; A Metzenberg; V Ionasescu; K Temple; S Kenwrick
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

9.  MASA syndrome is due to mutations in the neural cell adhesion gene L1CAM.

Authors:  L Vits; G Van Camp; P Coucke; E Fransen; K De Boulle; E Reyniers; B Korn; A Poustka; G Wilson; C Schrander-Stumpel
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

10.  Mutations in GDI1 are responsible for X-linked non-specific mental retardation.

Authors:  P D'Adamo; A Menegon; C Lo Nigro; M Grasso; M Gulisano; F Tamanini; T Bienvenu; A K Gedeon; B Oostra; S K Wu; A Tandon; F Valtorta; W E Balch; J Chelly; D Toniolo
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

View more
  41 in total

1.  Downregulation of the creatine transporter SLC6A8 by JAK2.

Authors:  Manzar Shojaiefard; Zohreh Hosseinzadeh; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2012-03-11       Impact factor: 1.843

2.  Characterization of novel SLC6A8 variants with the use of splice-site analysis tools and implementation of a newly developed LOVD database.

Authors:  Ofir T Betsalel; Efraim H Rosenberg; Ligia S Almeida; Tjitske Kleefstra; Charles E Schwartz; Vassili Valayannopoulos; Omar Abdul-Rahman; Nicola Poplawski; Laura Vilarinho; Philipp Wolf; Johan T den Dunnen; Cornelis Jakobs; Gajja S Salomons
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

3.  Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome.

Authors:  Vassili Valayannopoulos; Naziha Bakouh; Michel Mazzuca; Luc Nonnenmacher; Laurence Hubert; Fatna-Léa Makaci; Allel Chabli; Gajja S Salomons; Caroline Mellot-Draznieks; Emilie Brulé; Pascale de Lonlay; Hervé Toulhoat; Arnold Munnich; Gabrielle Planelles; Yves de Keyzer
Journal:  J Inherit Metab Dis       Date:  2012-05-30       Impact factor: 4.982

4.  X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology.

Authors:  Amy J Clark; Efraim H Rosenberg; Ligia S Almeida; Tim C Wood; Cornelis Jakobs; Roger E Stevenson; Charles E Schwartz; Gajja S Salomons
Journal:  Hum Genet       Date:  2006-04-26       Impact factor: 4.132

5.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.

Authors:  Hilde Van Esch; Marijke Bauters; Jaakko Ignatius; Mieke Jansen; Martine Raynaud; Karen Hollanders; Dorien Lugtenberg; Thierry Bienvenu; Lars Riff Jensen; Jozef Gecz; Claude Moraine; Peter Marynen; Jean-Pierre Fryns; Guy Froyen
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

6.  Identification of a 650 kb duplication at the X chromosome breakpoint in a patient with 46,X,t(X;8)(q28;q12) and non-syndromic mental retardation.

Authors:  J J Cox; S T Holden; S Dee; J I Burbridge; F L Raymond
Journal:  J Med Genet       Date:  2003-03       Impact factor: 6.318

Review 7.  Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.

Authors:  F Sedel; I Gourfinkel-An; O Lyon-Caen; M Baulac; J-M Saudubray; V Navarro
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

8.  Creatine transporters: a reappraisal.

Authors:  Oliver Speer; Lukas J Neukomm; Robyn M Murphy; Elsa Zanolla; Uwe Schlattner; Hugues Henry; Rodney J Snow; Theo Wallimann
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

9.  Infantile convulsions with paroxysmal dyskinesia (ICCA syndrome) and copy number variation at human chromosome 16p11.

Authors:  Patrice Roll; Damien Sanlaville; Jennifer Cillario; Audrey Labalme; Nadine Bruneau; Annick Massacrier; Marc Délepine; Philippe Dessen; Vladimir Lazar; Andrée Robaglia-Schlupp; Gaëtan Lesca; Elisabeth Jouve; Gabrielle Rudolf; Jacques Rochette; G Mark Lathrop; Pierre Szepetowski
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

10.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.